Morgan Stanley’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
97,055
-8,312
-8% -$186K ﹤0.01% 4901
2025
Q4
$4.5M Buy
105,367
+6,036
+6% +$307K ﹤0.01% 4254
2025
Q3
$5.27M Buy
99,331
+10,555
+12% +$583K ﹤0.01% 4107
2025
Q2
$4.01M Buy
88,776
+66,678
+302% +$1.92M ﹤0.01% 4236
2025
Q1
$456K Sell
22,098
-429
-2% -$8.53K ﹤0.01% 5368
2024
Q4
$333K Buy
22,527
+20,393
+956% +$180K ﹤0.01% 5583
2024
Q3
$16.3K Sell
2,134
-15,830
-88% -$186K ﹤0.01% 6565
2024
Q2
$279K Buy
17,964
+2,409
+15% +$57.4K ﹤0.01% 5533
2024
Q1
$505K Sell
15,555
-28,794
-65% -$1.21M ﹤0.01% 5304
2023
Q4
$2.55M Sell
44,349
-8,123
-15% -$493K ﹤0.01% 4784
2023
Q3
$3.53M Buy
52,472
+37,879
+260% +$2.8M ﹤0.01% 3990
2023
Q2
$1.23M Buy
14,593
+6,431
+79% +$344K ﹤0.01% 4707
2023
Q1
$346K Sell
8,162
-17,773
-69% -$803K ﹤0.01% 5459
2022
Q4
$1.19M Sell
25,935
-32,916
-56% -$2.63M ﹤0.01% 4767
2022
Q3
$6.73M Sell
58,851
-22,262
-27% -$3.68M ﹤0.01% 3394
2022
Q2
$17.8M Buy
81,113
+21,870
+37% +$4.32M ﹤0.01% 2421
2022
Q1
$11.1M Sell
59,243
-9,635
-14% -$1.59M ﹤0.01% 2794
2021
Q4
$12.2M Buy
68,878
+2,785
+4% +$496K ﹤0.01% 2719
2021
Q3
$14.9M Buy
66,093
+2,724
+4% +$737K ﹤0.01% 2415
2021
Q2
$24.1M Buy
63,369
+16,065
+34% +$4.98M ﹤0.01% 1958
2021
Q1
$10.5M Buy
47,304
+13,634
+40% +$3.92M ﹤0.01% 2592
2020
Q4
$10.8M Buy
33,670
+33,350
+10,422% +$11.1M ﹤0.01% 2433
2020
Q3
$131K Sell
320
-304
-49% -$134K ﹤0.01% 5303
2020
Q2
$269K Buy
+624
New +$252K ﹤0.01% 4935

Other funds holding CTEV

Morgan Stanley's CTEV Position: Q1 2026 in Review

Morgan Stanley reduced its Claritev Corp (CTEV) stake by 7.9% in Q1 2026, selling an estimated $186K and leaving 97,055 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4901.

Morgan Stanley first reported a position in CTEV in Q2 2020 and has held it in 24 quarters since. The position peaked at $24.1M in Q2 2021. 94 funds tracked by Wall St. Rank hold CTEV as of Q1 2026.

  • Morgan Stanley held 97,055 shares of Claritev Corp worth $1.59M as of Q1 2026.
  • Morgan Stanley sold 8,312 Claritev Corp shares in Q1 2026, an estimated $186K.
  • Claritev Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4901 holding.
  • Morgan Stanley first reported a position in Claritev Corp in Q2 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Claritev Corp position peaked at $24.1M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.